121 related articles for article (PubMed ID: 1106842)
21. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
[No Abstract] [Full Text] [Related]
22. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.
Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B
Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of DTIC (NSC-45388) in animals.
Venditti JM
Cancer Treat Rep; 1976 Feb; 60(2):135-40. PubMed ID: 1260771
[No Abstract] [Full Text] [Related]
24. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
Einhorn LH; Furnas B
Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for benign and locally aggressive tumors: report of two cases.
Hensley MF; Cangir A; van Eys J; Goepfert H
Cancer Treat Rep; 1978 Jan; 62(1):167-8. PubMed ID: 203394
[No Abstract] [Full Text] [Related]
27. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
[TBL] [Abstract][Full Text] [Related]
28. [Combined chemotherapy of neuroblastoma. 1st results in 40 children with metastatic form].
Zucker JM; Mercier JC
Arch Fr Pediatr; 1976; 33(6):555-67. PubMed ID: 949221
[TBL] [Abstract][Full Text] [Related]
29. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
Carbone PP; Costello W
Cancer Treat Rep; 1976 Feb; 60(2):193-8. PubMed ID: 769973
[TBL] [Abstract][Full Text] [Related]
30. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
Johnson RO; Metter G; Wilson W; Hill G; Krementz E
Cancer Treat Rep; 1976 Feb; 60(2):183-7. PubMed ID: 769971
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study.
Nitschke R; Starling K; Lui VK; Pullen J
Cancer Treat Rep; 1981; 65(11-12):1105-8. PubMed ID: 7028253
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
[No Abstract] [Full Text] [Related]
33. Chemotherapy of non-resectable soft tissue sarcomas.
Kessinger A; Foley JF; Lemon HM
Nebr Med J; 1975 May; 60(5):147-153. PubMed ID: 1128734
[No Abstract] [Full Text] [Related]
34. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY
Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802
[No Abstract] [Full Text] [Related]
35. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
[No Abstract] [Full Text] [Related]
36. Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma.
Green AA; Hayes FA; Hustu HO
Cancer; 1981 Nov; 48(10):2310-7. PubMed ID: 7296480
[TBL] [Abstract][Full Text] [Related]
37. [Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
Huber H; Grünewald K
Wien Klin Wochenschr; 1978 Dec; 90(24):861-4. PubMed ID: 369151
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
39. Experimental studies at Southern Research Institute with DTIC (NSC-45388).
Montgomery JA
Cancer Treat Rep; 1976 Feb; 60(2):125-34. PubMed ID: 1260770
[TBL] [Abstract][Full Text] [Related]
40. [Neuroblastoma study NBL79-society of pediatric oncology -- report after 1 year (author's transl)].
Berthold F; Treuner J; Niethammer D; Lampert F
Klin Padiatr; 1981 May; 193(3):198-201. PubMed ID: 6167757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
